Riccardo Scartazzini

This inventor holds 20 USPTO granted patents, primarily in Cephalosporin Chemistry. Top assignees: Ciba-Geigy Corporation, Fujisawa Pharmaceutical Company, Ltd.. Active years: 1976-1988.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Riccardo Scartazzini. Retrieved from https://idiyas.com/inventor/riccardo-scartazzini

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20

% Patents Active = 100.0

Average Co-Inventor Count = 2.1

ph-index = 6

Forward Citations = 98(Granted Patents)

Location History:

Basel, CH (1981 - 1985)
Allschwil, CH (1976 - 1988)

Company Filing History:

19 out of 6,858

Ciba-Geigy Corporation

patents

1 out of 940

Fujisawa Pharmaceutical Company, Ltd.

patents

Years Active: 1976-1988

Loading Chart...

Areas of Expertise:

Cephalosporin Compounds

Cepham Derivatives

Aminocarboxylic Acid

8-Oxo-5-Thia

Crystalline Salts

3-Hydroxy Compounds

7-Thiazolyl-Acetamido

Fragmentation Procedure

Mercaptoalcohols

Cycloalkylmethyleneaminopenam

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 4735937 - 8-oxo-5-thia-1-azabicyclo(4,2,0)oct-2-ene compounds (1988-04-05),

2. 4668781 - Ceph-3-one compounds and process for their manufacture (1987-05-26),

3. 4591642 - Cephem and cepham derivatives (1986-05-27),

4. 4508723 - 6-Azaoligocycloalkylmethyleneaminopenam compounds (1985-04-02),

5. 4477658 - Process for the preparation of cepham and cephem compounds (1984-10-16),

6. 4467101 - Compounds with terminal aminocarboxylic acid grouping (1984-08-21),

7. 4464366 - Cephem compounds having a terminal aminocarboxylic acid grouping and (1984-08-07),

8. 4436903 - Process for the production of 7 (1984-03-13),

9. 4430498 - 8-Oxo-5-thia-1-azabicyclo(4,2,0)oct-2-ene compounds (1984-02-07),

10. 4411897 - Crystalline salts (1983-10-25),

11. 4405778 - Process for preparing cephalosporin ethers (1983-09-20),

12. 4389524 - Cepham compounds (1983-06-21),

13. 4374134 - Cephalosporin compounds with terminal aminocarboxylic acid groupings and (1983-02-15),

14. 4313945 - 7-Thiazolyl-acetamido-cephem derivatives with terminal aminocarboxylic (1982-02-02),

15. 4301279 - Process for the production of 3-hydroxy compounds (1981-11-17),

Title: The Innovations of Riccardo Scartazzini

Introduction

Riccardo Scartazzini is a notable inventor based in Allschwil, Switzerland, recognized for his significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 20 patents, Scartazzini has made strides in the development of compounds with antibiotic properties, showcasing innovation that addresses critical healthcare needs.

Latest Patents

Among his latest patents, the invention concerning 8-oxo-5-thia-1-azabicyclo(4,2,0)oct-2-ene compounds stands out. This invention regards 7-amino-ceph-3-em-4-carboxylic acid compounds, where specific groups serve as functional components that enhance their pharmacological efficacy. These compounds demonstrate antibiotic properties, marking a substantial advancement in medicinal chemistry.

Another noteworthy patent is related to Ceph-3-one compounds and processes for their manufacture. This invention focuses on 7.beta.-amino-cepham-3-one-4-carboxylic acid compounds, particularly esters and their N-substituted derivatives. These compounds serve as intermediates for producing enol ethers and esters that exhibit remarkable pharmacological effects, further underscoring Scartazzini's innovative capacity within the field.

Career Highlights

Riccardo Scartazzini's career spans notable tenures at leading pharmaceutical companies. He has worked with Ciba-Geigy Corporation and Fujisawa Pharmaceutical Company, Ltd., contributing to cutting-edge research and development efforts. These experiences have honed his expertise and fortified his impact within the industry.

Collaborations

Throughout his career, Scartazzini has collaborated with esteemed colleagues, including Hans Bickel and Bruno Fechtig. These partnerships have fostered an environment of innovation and have been instrumental in the successful development of his patented compounds.

Conclusion

With a solid foundation of patents and a history of collaboration within prominent pharmaceutical companies, Riccardo Scartazzini exemplifies the spirit of innovation in the biomedical field. His contributions not only advance scientific knowledge but also provide valuable solutions for improving healthcare outcomes.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]